Evidence map›Paper›PMID 32595377›Full record

ReviewSisli Etfal Hastanesi tip bulteni2018

Neonatal Diabetes Mellitus.

Adil Umut Zübarioğlu, Ali Bülbül, Hasan Sinan Uslu

Open access · bronzeAbstract readReview
In one paragraph

Review in Sisli Etfal Hastanesi tip bulteni, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Permanent Neonatal Diabetes with High Insulin Requirements due to a New Variant in theJournal of clinical research in pediatric endocrinology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Adil Umut ZübarioğluDepartment of Neonatology, Health Sciences University Istanbul Sisli Hamidiye Etfal Health Practice and Research Center, Istanbul, Turkey.
Ali BülbülDepartment of Neonatology, Health Sciences University Istanbul Sisli Hamidiye Etfal Health Practice and Research Center, Istanbul, Turkey.
Hasan Sinan UsluDepartment of Neonatology, Health Sciences University Istanbul Sisli Hamidiye Etfal Health Practice and Research Center, Istanbul, Turkey.
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal diabetes is a rare cause of hyperglycemia in the neonatal period. It is caused by mutations in genes that encode proteins playing critical roles in normal functions of pancreatic beta cells. Neonatal diabetes is divided into temporary and permanent subtypes. Treatment is based on the correction of fluid-electrolyte disturbances and hyperglycemia. Patients respond to insulin or sulfonylurea treatment according to the mutation type. Close glucose monitoring and education of caregivers about diabetes are vital.

Indexed as

Insulin therapyneonatal diabetes mellitussulfonylurea

Identifiers

PMID32595377
PMCPMC7315067
OpenAlexW2794848797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.